FOXO4 peptidedosage
The FOXO4 peptide, particularly the FOXO4-DRI variant, is an emerging therapeutic agent recognized for its potential to target cellular senescence. Cellular senescence, a state where cells cease to divide and accumulate with age, has been linked to various age-related diseases and functional decline.BuyFOXO4blockingpeptide-NP_005929 (MBS152701) product datasheet at MyBioSource, BlockingPeptides. Application: Blocking (BL) FOXO4-DRI acts as a senolytic peptide, selectively inducing apoptosis (programmed cell death) in these senescent cells, thereby potentially mitigating their detrimental effects on tissues and organs. This mechanism offers a novel approach to combatting aging and improving healthspan.
FOXO4-DRI is a synthetic peptide designed to disrupt the interaction between the FOXO4 protein and p53. FOXO4 is a transcription factor involved in cellular survival pathways, and its dysregulation, particularly in senescent cells, contributes to their persistence. The p53 protein, a critical tumor suppressor, also plays a role in the senescence process.Peptide inhibitors targeting FOXO4-p53 interactions and ... By interfering with the FOXO4-p53 complex, FOXO4-DRI effectively triggers the self-destruction of senescent cellsFOXO4-DRI is a cell-permeablepeptideantagonist that blocks the interaction ofFOXO4and p53.FOXO4-DRI is a senolyticpeptidethat induces apoptosis of .... Studies have shown that this peptide can selectively remove senescent cells from various tissues, including chondrocytes and fibroblasts, and has demonstrated efficacy in preclinical models.Current perspective on the regulation of FOXO4 and its role in disease ...
The primary application of the FOXO4 peptide lies in its senolytic properties, making it a promising candidate for anti-aging strategies and the treatment of age-related conditions. Research suggests several potential benefits:
* Alleviating Age-Related Decline: Preclinical studies in aged mice have indicated that FOXO4-DRI can improve the testicular microenvironment and alleviate age-related testosterone secretion insufficiency. This points to its potential in restoring hormonal balance and function in aging individuals.FOXO4-DRI alleviates age-related testosterone secretion ...
* Combating Tissue Fibrosis: Emerging research indicates that FOXO4 peptides can target myofibroblasts, potentially ameliorating conditions like bleomycin-induced pulmonary fibrosis by influencing the extracellular matrix receptor interaction pathwayHuman FOXO4 Synthetic Peptide (PEP-1088).
* Reducing Chemotoxicity: FOXO4-DRI has shown promise in reversing doxorubicin-induced chemotoxicity in mice, leading to improved body weight and reduced liver damage markers. This suggests a role in protecting against the side effects of certain medical treatments.
* Promoting Tissue Regeneration: By clearing senescent cells, which can impede tissue repair, FOXO4-DRI may indirectly support tissue regeneration and improve overall tissue health.
The scientific community is actively investigating the FOXO4 peptide and its therapeutic potential. Numerous studies focus on its interaction with p53, its role in inducing apoptosis in senescent cells, and its effects across various biological systems. While much of the current research is preclinical, the development of FOXO4-DRI as a senolytic peptide for targeted cell clearance represents a significant advancement in the field of regenerative medicine and anti-aging therapiesSenolytic Peptide FOXO4-DRI Selectively Removes Senescent .... The peptide's ability to selectively target and eliminate senescent cells offers a precise approach to addressing the root causes of age-related decline.
As with any emerging therapeutic, there are important considerations regarding the use of FOXO4 peptidesFoxO4 (55D4) Rabbit Monoclonal Antibody #2499. The precise dosage and administration protocols are subjects of ongoing research and clinical investigation. While promising, the long-term effects and potential side effects in humans require further comprehensive studyFOXO4 D-Retro-Inverso(DRI) peptide. The development of FOXO4-DRI as a cell-permeable peptide antagonist highlights its advanced design for cellular penetration and targeted action.Description. Thepeptideis used to block Anti-FOXO4(pS197) Antibody (orb214250) reactivity. Research Area. Cancer, Developmental Biology, Epigenetics. Images ... Availability is often through specialized research chemical suppliers, and its application is primarily within research settings or under clinical investigation.Peptide Therapy for Anti-Aging: How It Works and What to Expect
The FOXO4 peptide, particularly in its FOXO4-DRI form, stands out as a significant development in the quest to combat cellular senescence and its associated health issues. Its targeted mechanism of action, inducing apoptosis in senescent cells, offers a novel therapeutic avenue for age-related conditions, tissue regeneration, and improving overall healthspanMolecular modelling of the FOXO4-TP53 interaction to .... While research is ongoing, the potential benefits observed in preclinical studies underscore the promise of FOXO4 peptide therapy in the future of medicine.作者：HH Le·2021·被引用次数：41—FOXO4and TP53 are multi-domain proteins that interact with each other and stimulate senescence (Fig. 1a). It was previously shown that TP53 disrupts the ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.